Nuvation Bio Inc. (NUVB) NYSE
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 3.06B |
| Enterprise Value | 2.91B |
| P/E Ratio | -15.95 |
| PEG Ratio | -0.49 |
| Price/Sales Ratio | 14.16 |
| Price/Book Ratio | 9.52 |
| Enterprise/Revenue | 14.12 |
| Enterprise/EBITDA | -18.89 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
Profitability
| Profit Margin | -0.88 |
| Operating Margin | -0.81 |
AD
Management Effectiveness
| Return On Assets | -0.2 |
| Return On Equity | -0.5 |
Income Statement
| Revenue | 62.9M |
| Revenue/Share | 0.49 |
| Gross Profit | 54.46M |
| EBITDA | -189.21M |
| Net Income | -204.63M |
| Diluted EPS | -0.6 |
Balance Sheet
| Total Cash | 660.96M |
| Total Cash/Share | 1.9 |
| Total Debt | 252.14M |
| Total Debt/Equity | 0.99 |
| Current Ratio | 8.37 |
| Book Value Per Share | 0.73 |
Price History
| 52-Week Change | 138.97 |
| 52-Week High | 9.75 |
| 52-Week Low | 2.84 |
| Moving Average 50 Days | 6.08 |
| Moving Average 200 Days | 5.86 |
Statistics
| Average Volume | 6.81M |
| Shares Outstanding | 347.2M |
| % Held by Institutions | 67.67 |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
AD
